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A B S T R A C TIn vitro generation of red blood cells has become a goal for scientists globally. Directly, in vitro-generated red blood
cells (RBCs) may close the gap between blood supply obtained through blood donation and high demand for
therapeutic uses. In addition, the cells obtained can be used as a model for haematologic disorders to allow the
study of their pathophysiology and novel treatment discovery. For those reasons, a number of RBC culture systems
have been established and shown to be successful; however, the cost of each millilitre of packed RBC is still
extremely high. In order to reduce the cost, we aim to see if we can reduce the number of factors used in the
existing culture system. In this study, we examined how well haematopoietic stem cells proliferate and
differentiate into mature red blood cells with modiﬁed culture system.
 Absence of extra heparin or insulin or both from the erythroid differentiation media did not affect
haematopoietic stem cell proliferation and differentiation.
Therefore, we show that the cost and complexity of erythroid culture can be reduced, which may improve the
feasibility of in vitro generation of red blood cells.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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Subject Area  Biochemistry, Genetics and Molecular BiologyErythropoiesisMore speciﬁc subject area: 
Method name: A 3-stage erythroid culture system
Name and reference of
original methodA 3-stage erythroid culture system from: Grifﬁths RE, Kupzig S, Cogan N, Mankelow TJ, Betin
VM, Trakarnsanga K, et al. Maturing reticulocytes internalize plasma membrane in
glycophorin A-containing vesicles that fuse with autophagosomes before exocytosis. Blood.
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Blood shortage is an important health care problem around the world, especially in developing
countries. At present, blood donation is the only way that provides blood supplies for transfusion. It
has been reported by WHO that 110 million blood units are collected globally every year, however
shortage of blood supply still occurs in several countries especially in developing countries [1]. In
some situations, such as during war or an epidemic, the demand for blood outweighs supply and
patients perish.
However, even in situations when blood supply is adequate, problems still arise. The proportion of
different blood groups varies between people in different countries and of different ethnicities. Those
individuals with rare blood groups have a higher risk of suitable blood not being available. Also,
patients with diseases such as thalassemia, renal failure and cancer usually suffer chronic anemia.
Most will need serial blood transfusions, which can stimulate immunity to minor blood group
antigens, and cause ‘transfusion reaction’. This reaction can increase morbidity and mortality of
patients. Therefore, it is important to have fully compatible blood for transfusion. Moreover, there are
many infectious agents that can be transmitted via blood, such as hepatitis B virus, HIV and prions.
Thus, extensive efforts are made to check that every unit of blood is safe from such agents – a
procedure that is not 100% safe, and is also expensive. Hence, to overcome many of these problems,
efforts are being made globally to develop system to generate red blood cells (RBCs) in vitro from stem
cell sources. Different culture systems are used and varying amounts of mature RBCs are produced [2–
7]. However, systems to generate RBCs in vitro have not yet achieved a clinical grade transfusion
product due to the complicated processes involved. RBC production requires many cytokines and
growth factors during the various developmental stages, which results in high cost of production. In
2012, Grifﬁths et al. has developed a culture system that can promote >105 fold expansion of erythroid
cells derived from haematopoietic stem cells in adult peripheral blood which achieved very high
enucleation rate (up to 95%) [8]. The culture media in this culture system contains several cytokines
and growth factors including heparin and insulin. Heparin is a factor that promotes stem cell
proliferation and haematopoiesis [9,10]. Insulin is a growth factor that helps regulate cellular
metabolism and promote growth and differentiation of several cell types including erythroid cells [11–
15]. The aim of this study was to optimize this existing erythroid culture system in order to reduce the
cost of production. We show that absence of heparin and insulin from the existing erythroid
differentiation media did not affect hematopoietic stem cell proliferation and differentiation;
therefore the cost and complexity of erythroid culture can be reduced, which may improve the
feasibility of in vitro generation of red blood cells.
Material and methods
Isolation of adult CD34+ cells
Leucocyte reduction system (LRS) cones were obtained from healthy donors with written informed
consent for research use in accordance with the Declaration of Helsinki and approved by Siriraj
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of the experiment (n = 3). CD34+ cells were isolated from the peripheral blood mononuclear cell
fraction using a MiniMacs direct CD34+ progenitor cell isolation kit (Miltenyi Biotech Ltd.) following
the manufacturer’s instructions, as brieﬂy stated below.1 Blood samples were ﬁrst diluted with Hanks’ Balanced salt solution (HBSS)(Sigma-Aldrich)
containing 0.6% (v/v) citrate dextrose solution (ACD)(Sigma-Aldrich) and separated on a Ficoll-
Histopaque density gradient (Histopaque1-1077 Hybri-MaxTM, Sigma-Aldrich) at 400 g for 30 min
at 20 C.2 The mononuclear cells at the middle interface layer were harvested and washed 2–4 times with
HBSS containing 0.6% ACD to remove platelet clumps.3 The harvested cells were incubated in pre-warm red cell lysis buffer (150 mM NH4Cl (Sigma-
Aldrich), 1 mM EDTA.2H20 (BDH Laboratory Supplies) and 10 mM KHCO3 (BDH Laboratory
Supplies), pH-adjusted to 7.5 using NaOH (Fisher Scientiﬁc)) for 12 min at room temperature.4 After washing with HBSS containing 0.6% ACD, the cells were pooled into cold MACs buffer (0.5%
Bovine serum albumin (Sigma-Aldrich), 0.6% Citrate phosphate dextrose (CPD) (Sigma-Aldrich) in
1x PBS (Sigma-Aldrich)) and spun down at 400 g for 5 min at 20 C.5 After centrifugation and supernatant was discarded, 500 ml MACs buffer, 100 ml MACS-Fc blocking
agent and 100 ml MACS-CD34 beads for up to 108 cells were added to the cell pellets. The cell
suspension were then incubated at 4 C for 30 min with constant mixing (on a roller).6 The cells were applied to a LS column. The column was washed with cold MACS buffer and the cells
were also eluted with cold MACS buffer before applying to a MS column. Finally, a total of 1.5 ml
MACS buffer was passed through the MS column and the CD34+ cells were eluted in 1 ml MACS
buffer.
Erythroid differentiation of CD34+ cells
The CD34+ cells were cultured using the 3-stage erythroid culture system. During the ﬁrst 8 days
the cells were maintained in Basic medium which was Iscove’s medium (Biochrom) containing 3% (v/
v) human AB serum (Sigma-Aldrich), 2% fetal calf serum (Hyclone, Fisher Scientiﬁc, Ltd), 10 mg/ml
insulin (Sigma-Aldrich), 3 U/ml heparin (Sigma-Aldrich), 3 U/ml EPO (Roche), 200 mg/ml transferrin
(R&D Systems) and 1 U/ml penicillin/streptomycin (Sigma-Aldrich) supplemented with 10 ng/ml SCF
(R&D Systems) and 1 ng/ml IL-3 (R&D Systems) (primary medium). IL-3 and SCF were withdrawn from
the medium on day 8 (secondary medium) and 11 (tertiary medium), respectively. In addition, extra
transferrin was added to the medium to the ﬁnal concentration of 500 mg/ml from day 11 onward. The
cells were also cultured in the culture media without insulin and/or heparin as indicated. Cells were
counted and medium was added every other day. The cultured cells were maintained at 37 C, 5% CO2
throughout the culture period. At indicated time points, aliquots of cells were collected for
morphological analysis using cytospin and Leishman staining. Two-sample equal variance t-test was
carried out to determine the statistical signiﬁcances of the differences in cell numbers and cell types in
the original versus the modiﬁed culture.
Results
Heparin does not alter erythroblast proliferation in culture
To study the effect of heparin on the proliferation of erythroblasts, the isolated CD34+
haematopoietic stem cells from adult peripheral blood (isolated from leukocyte-reduction system
cones) were divided into 2 groups. Aliquots of approximately 104 CD34+ cells were maintained in the
media of a 3-stage erythroid culture system containing heparin or without heparin. The numbers of
erythroid cells were evaluated every other day. There was no difference in the number of cells between
the group maintained in the media without heparin and those with heparin (Fig. 1, n = 3, p > 0.05 at
every time point).
Fig. 1. Comparison of the numbers of erythroid cells maintained in the culture media with heparin or without heparin
(mean  SD; n = 3, p > 0.05 as analyzed by Student’s t-test).
Fig. 2. Comparison of the numbers of erythroid cells maintained in the culture media with insulin or without insulin
(mean  SD; n = 3, p > 0.05 as analyzed by Student’s t-test).
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Next the effect of insulin on the proliferation of erythroblasts was studied. The isolated CD34+
haematopoietic stem cells from adult peripheral blood were divided into 2 groups similar to in the
previous experiment. The CD34+ haematopoietic stem cells were maintained in the media with or
without insulin. Similar to the previous study, there was no difference in the number of cells between
the two groups at every time point (Fig. 2, n = 3, p > 0.05).
Heparin and insulin are not required for the erythroid culture system
Due to the observation in Figs. 1 and 2, further experiment was then performed to determine
whether both heparin and insulin are required for the erythroid culture system. The isolated CD34+
haematopoietic stem cells were divided into 2 groups. The ﬁrst group was maintained in the media
with heparin and insulin, whereas the other group was maintained in the media without both insulinFig. 3. Comparison of the numbers of erythroid cells maintained in the culture media with or without heparin and insulin
(mean  SD; n = 3, p > 0.05 as analyzed by Student’s t-test).
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Table 1
Morphological analysis of erythroid cells at different time points maintained in the media with and without heparin and insulin
(mean  SD, n = 3).
Day Insulin/
Heparin +/
Proerythroblasts Basophillic
erythroblasts
Polychromatic
erythroblasts
Orthochromatic
erythroblasts
Reticulocytes
Day 8 + 68.4%  2.5% 27.7%  1.3% 3.9%  1.2% 0% 0%
– 71.2%  2.3% 26.4%  1.4% 2.5%  0.9% 0% 0%
Day 11 + 43.7%  3.5% 17.4%  2.5% 22.1%  2.5% 13.5%  1.5% 3.3%  1.1%
– 46.4%  2.8% 23.7%  2.4% 18.2%  2.9% 8.4%  1.4% 3.3%  0.7%
Day 14 + 4.8%  1.3% 20.6%  1.7% 30.1%  2.8% 28.6%  3.9% 15.9%  1.2%
– 3.1%  1.1% 19.2%  1.6% 27.8%  2.1% 29.5%  3.8% 20.4%  4%
Day 17 + 0% 0% 0.7%  1.2% 28.8%  1.8% 70.5%  2.2%
– 0% 0% 1%  1.7% 29.3%  2.4% 69.7%  1.7%
Day 20 + 0% 0% 0% 9.7%  1.1% 90.3%  1.1%
– 0% 0% 0% 10.3%  1.2% 89.7%  1.2%
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cells evaluated every other day. There was no difference in the number of cells between the two groups
(Fig. 3, n = 3, p > 0.05 at every time point).
The morphology of cultured cells was analyzed by cytospin and Leishman staining throughout the
culture. There was no signiﬁcant difference in morphology of cells between both groups (Fig. 4 and
Table 1) with similar percentages of enucleation obtained on day 20: 90.27%  1.12% for the control
group and 89.70%  1.21% for the group maintained in the media without insulin and heparin
(mean  SD, n = 3, p > 0.05 as analyzed by Student’s t-test).
Discussion
Several culture systems have been established for the generation of red blood cells in vitro. These
culture systems require a number of cytokines and growth factors, which results in high cost of
production. Some factors used in erythroid culture system are common among these cultures
including stem cell factor, erythropoietin and transferrin [2,3,6,7], which indicates that they are
necessary for erythroid differentiation. However, some factors such as insulin and heparin are used
only in some culture systems [2,3,6] and these two factors are present in our culture media. As we are
using this culture to study haematopoiesis due to its ability to achieve up to 95% enucleation rate, we
aimed to optimize it to reduce the cost. Interestingly, we have observed in this study that heparin and
insulin, which have been believed to promote erythroid proliferation and maturation [11–15], are not
required for our culture system. Therefore it can be omitted if this culture system is selected for
erythroid differentiation from adult haematopoietic stem cells. Since haematopoitic stem cells from
different individuals have variation in their proliferation capacity, the numbers of cells (y-axis)
obtained from different experiments (Figs. 1–3) in this study were slightly different. However, within
the same experiment we show comparable expansion between different conditions when using
haematopoitic stem cells from the same individuals. This information could then be useful for the
development of in vitro erythroid culture system because the high cost of production is one of the
limitations of this process.Fig. 4. Erythroid cells maintained in the media with and without heparin and insulin stained with Leishman reagent and
analyzed by light microscopy (scale bars 10 mm). Black arrows indicate proerythroblasts; blue arrows indicate basophilic
erythroblasts; red arrows indicate polychromatic erythroblasts; green arrows indicate orthochromatic erythroblasts; yellow
arrows indicate reticulocytes (These images are representative of three cultures).
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